Elicio Therapeutics, Inc.ELTXNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank46
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P46
Within normal range
vs 5Y Ago
-0.1x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-8.56%
Q3 2025-4.21%
Q2 20254.92%
Q1 2025-0.12%
Q4 2024-26.60%
Q3 2024143.73%
Q2 2024-35.66%
Q1 2024-9.82%
Q4 2023-12.40%
Q3 2023-17.63%
Q2 2023-9.93%
Q1 202384.29%
Q4 2022-63.04%
Q3 20220.00%
Q2 20220.00%
Q1 2022-15.81%
Q4 2021-12.21%
Q3 2021-12.30%
Q2 2021555.51%
Q1 2021-59.61%
Q4 2020108.17%
Q3 20200.00%
Q2 20200.00%
Q1 20200.00%
Q4 20190.00%